Nilotinib Treatment-free Remission Study in CML (Chronic Myeloid Leukemia) Patients

Clinical trial NCT01784068 · COMPLETED

Trial details

NCT number: NCT01784068
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Myelogenous Leukemia

Start date: 2013-03-19
Primary completion: 2016-05-31
Enrollment: 215

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.